InsidersTradesSigma
Browse the full record of transactions filed by VOGELBAUM MARTIN, Director. Officer active across 1 companies, notably Cara Therapeutics, Inc.. Cumulatively, 3 reports have been logged. The latest transaction was filed on 2 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Martin Vogelbaum is a Board Member of Cara Therapeutics, Inc. He brings valuable expertise in pharmaceutical product development. His role on the board involves guiding the company's strategic initiatives, which focus on pain management treatments.